Alithea Genomics

Alithea Genomics was founded in 2020, is headquartered in Epalinges, Switzerland, lists 11–50 employees, and has $7.2M in recorded funding across 2 rounds.

Headquarters
Epalinges, Vaud
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$7.2M
Last Round
$3.7M SeedMar 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Alithea Genomics delivers high-throughput transcriptomics kits and services for scalable RNA-seq, gene expression profiling, and compound screening. The company develops solutions that streamline the generation of big RNA data, including MERCURIUS DRUG-seq, FLASH-seq, and BRB-seq kits used for industrial-scale screening, toxicology, and target validation. Its offerings cover extraction-free workflows from cells, spheroids, blood, and plant samples for research and pharmaceutical customers.

Summary

Alithea Genomics is a Biotech company based in Epalinges, Switzerland, founded in 2020. It lists 11–50 employees. It has raised $7.2M in total across 2 rounds, most recently a $3.7M Seed round in Mar 2026. Investors include Zürcher Kantonalbank and TechU Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedMar 2026
$3.7M

Sign up to see all 2 events

Funding: Extension Round through Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
ConvertibleTotal funding$1.2BFeb 2021
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series ETotal funding$853.3MJun 2026
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alithea Genomics on Indexed.vc
<a href="https://indexed.vc/companies/alithea-genomics"><img src="https://indexed.vc/api/badge/company/alithea-genomics" alt="Alithea Genomics on Indexed.vc" width="260" height="76" /></a>